ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Pemigatinib for Cholangiocarcinoma with FGFR2 Fusions or Rearrangements"
Episode Synopsis
Arndt Vogel, MD, shares results from the phase 2, FIGHT-202 trial which evaluated pemigatinib in patients with previously treated, locally advanced or metastatic cholangiocarcinoma.
In God we trust